Tirzepatide, an innovative treatment developed for type 2 diabetes, draws the attention of the scientific community to its potential to protect the heart from damage caused by hyperglycemia and inflammation. According to a study published in Cardiovascular Diabetes, this advanced therapy reduces the risk of cardiac fibrosis and oxidative stress by lowering the levels of inflammatory markers such as TGF-beta and MMP9, and by stimulating BCL2 protective proteins. The benefits do not stop here: tirzepatide improves the mitochondrial function of myocardial cells, an essential aspect for preventing heart failure, and reduces vascular inflammation, a critical factor in preventing major cardiovascular events (Cardiovascular Medicine).
Diabetes: Your guide in managing diabetes and preventing complications
Platform Diabeta it is designed with an intuitive design that facilitates navigation and access to relevant information. Each section of the platform is logically organized, allowing users to quickly find what they are looking for. From SPCs (Summary of Product Characteristics) detailed to updated guides and protocols, everything is structured so as to be available to specialists, reducing time spent looking for the necessary resources.
An essential feature of Diabeta is quick access to up-to-date information on diabetes management. The platform provides the latest data from SPCs, as well as guides and treatment protocols, ensuring that health professionals always have the latest resources at their disposal. This allows doctors and other professionals to make informed decisions, based on the latest discoveries and recommendations in the field.
Diabeta it is not only a source of information, but also a practical tool that can be easily integrated into the daily routine of specialists. Whether it is a quick consultation of a treatment protocol or a verification of a drug’s specifications, the platform is designed to be a reliable partner in the clinical decision-making process. This allows for more efficient management of patients with diabetes, saving time and resources.
Diabetes: Your partner in the prevention of cardiovascular complications
platform Diabeta is essential for patients with diabetes, providing scientifically validated information on innovative treatments such as Tirzepatide, and relevant clinical results. They demonstrate a significant reduction in HbA1c, body weight and fat mass, helping to improve the management of type 2 diabetes. Diabeta supports specialists by providing information in an accessible way, emphasizing the importance of adapting treatments to the needs of each individual.
Diabeta was developed by a Romanian company, Apollo Technologies, specialized in creating professional applications based on artificial intelligence. The application is made available to doctors in professional medical communities administered by People and Companies, with the support of the partners Novo Nordisk, Boehringer Ingelheim and Medtronic.
